Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Micromachines|February 25, 2023
A Novel Space Robot with Triple Cable-Driven Continuum Arms for Space GraspingYicheng Dai, Zuan Li, Xinjie Chen, et al.
BMC Urology|June 4, 2020
The metabolic role of PFKFB4 in androgen-independent growth in vitro and PFKFB4 expression in human prostate cancer tissueXiming Li, Zhi Chen, Zuan Li, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 9, 2026
Sex and age disparities in goserelin safety: a global pharmacovigilance studyZizhen Liu, Han Qu, Zuan Li, et al.
Zhongguo Gu Shang = China Journal of Orthopaedics and Traumatology|September 27, 2021
[Intraoperative arthrography monitoring assisted closed reduction and internal fixation for intercondylar fracture of humerus in children]Wei Gong, Jian-Si Wang, Bing-Zuan Li, et al.
Frontiers in Immunology|December 11, 2025
A pharmacovigilance study of Bruton's tyrosine kinase inhibitors: a multidimensional analysis based on FAERS and VigiBaseHan Qu, Yuqi Jia, Zizhen Liu, et al.
Oncology Reports|July 23, 2021
Screening of hub genes and evaluation of the growth regulatory role of CD44 in metastatic prostate cancerJunhao Lin, Zhi Chen, Zuan Li, et al.
Oncology Reports|June 8, 2022
[Corrigendum] Screening of hub genes and evaluation of the growth regulatory role of CD44 in metastatic prostate cancerJunhao Lin, Zhi Chen, Zuan Li, et al.
BMC Cancer|December 6, 2022
Speckle-type POZ protein could play a potential inhibitory role in human renal cell carcinomaZhi Chen, Zuan Li, Chunlin Li, et al.
BMC Urology|August 22, 2022
Effect of AKT silence on malignant biological behavior of renal cell carcinoma cellsZuan Li, DeYong Nong, Bincai Li, et al.
Frontiers in Immunology|July 3, 2026
Real-world safety of first-line enfortumab vedotin plus pembrolizumab in advanced urothelial carcinoma: evidence from VigiBase and FAERSZuan Li, Han Qu, Shuowen Wang, et al.
Pageof 2